Only four tumor types showed a consistent alteration in mRNA levels of N-cadherin (gene: CDH2) across the independent datasets: increased CDH2 levels in thyroid (THCA) and kidney (KIRP), decreased CDH2 mRNA levels in colon (COAD) and prostate (PRAD) adenocarcinoma (Fig. 9 F; and Fig. S5, E and F). This evidence concerns the gene CDH2 and neoplasm.